The device, a Class II accessory intended for endoscopic procedures, received a Substantially Equivalent determination, allowing market access without the need for new clinical trials.
Neptune Medical, Inc. has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Pathfinder Endoscope Overtube. The decision, rendered on September 18, 2026, classifies the device as substantially equivalent to previously cleared predicate devices under product code FED, which encompasses endoscopes and accessories.
This clearance allows Neptune Medical to market the Pathfinder Endoscope Overtube as a Class II medical device. The specific regulation number cited for this product is 21 CFR 876.1500, pertaining to endoscopic accessories.
Device Specification and Intended Use
The Pathfinder Endoscope Overtube is designed to facilitate endoscopic procedures. While specific operational details and design features are not fully detailed in the summary clearance document, overtube devices typically provide a stable conduit for the endoscope, protect the esophageal or gastric mucosa during multiple insertions, and assist in tissue manipulation or foreign body retrieval.
The FDA's 'substantially equivalent' determination means the agency found the device as safe and effective as a legally marketed predicate device, often without requiring new clinical data.
This clearance process did not involve a full Pre-Market Approval (PMA) application, which is reserved for Class III devices requiring more extensive clinical evidence of safety and effectiveness. As a traditional 510(k) pathway, the review focused on demonstrating equivalence to existing technologies rather than proving novel clinical benefits.
Market Implications and Next Steps
The Pathfinder Endoscope Overtube falls under the purview of the Gastroenterology and Urology advisory committee, indicating its primary application in these medical specialties. The clearance decision enables Neptune Medical to begin commercialization activities, though details regarding manufacturing scale-up, distribution partnerships, or pricing strategy have not been publicly disclosed.
Further information regarding the device's specific applications, clinical utility in various endoscopic procedures, and post-market surveillance plans would typically emerge as the company initiates its market entry. The competitive landscape for endoscopic accessories includes established manufacturers, suggesting Neptune Medical will need to articulate a clear value proposition for the Pathfinder Overtube.
